Woodline Partners’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5M | Sell |
437,000
-1,707,814
| -80% | -$80.3M | 0.11% | 279 |
|
|
2025
Q1 | $94.7M | Buy |
2,144,814
+654,678
| +44% | +$28.9M | 0.62% | 18 |
|
|
2024
Q4 | $53.8M | Buy |
1,490,136
+108,512
| +8% | +$3.92M | 0.36% | 69 |
|
|
2024
Q3 | $44.3M | Buy |
1,381,624
+19,225
| +1% | +$616K | 0.37% | 78 |
|
|
2024
Q2 | $51.3M | Buy |
1,362,399
+495,175
| +57% | +$18.7M | 0.49% | 53 |
|
|
2024
Q1 | $42.7M | Buy |
867,224
+65,042
| +8% | +$3.2M | 0.39% | 71 |
|
|
2023
Q4 | $29.3M | Buy |
802,182
+610,809
| +319% | +$22.3M | 0.32% | 95 |
|
|
2023
Q3 | $4.42M | Buy |
191,373
+44,373
| +30% | +$1.03M | 0.05% | 328 |
|
|
2023
Q2 | $3.85M | Sell |
147,000
-1,300,389
| -90% | -$34.1M | 0.05% | 333 |
|
|
2023
Q1 | $37.3M | Buy |
+1,447,389
| New | +$37.3M | 0.51% | 44 |
|
|
2022
Q2 | – | Sell |
-233,210
| Closed | -$13.2M | – | 884 |
|
|
2022
Q1 | $13.2M | Sell |
233,210
-9,190
| -4% | -$519K | 0.21% | 141 |
|
|
2021
Q4 | $15M | Buy |
242,400
+229,074
| +1,719% | +$14.2M | 0.22% | 129 |
|
|
2021
Q3 | $845K | Sell |
13,326
-82,132
| -86% | -$5.21M | 0.01% | 522 |
|
|
2021
Q2 | $7.87M | Sell |
95,458
-79,870
| -46% | -$6.58M | 0.15% | 165 |
|
|
2021
Q1 | $12.9M | Buy |
175,328
+45,496
| +35% | +$3.35M | 0.29% | 94 |
|
|
2020
Q4 | $9.42M | Sell |
129,832
-92,544
| -42% | -$6.71M | 0.25% | 120 |
|
|
2020
Q3 | $10.6M | Buy |
222,376
+59,861
| +37% | +$2.85M | 0.35% | 82 |
|
|
2020
Q2 | $6.83M | Sell |
162,515
-48,378
| -23% | -$2.03M | 0.27% | 92 |
|
|
2020
Q1 | $5.69M | Buy |
+210,893
| New | +$5.69M | 0.41% | 77 |
|